Glanbia plc (OTCMKTS:GLAPF – Get Free Report)’s share price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $25.76 and traded as high as $27.83. Glanbia shares last traded at $27.83, with a volume of 100 shares trading hands.
Analysts Set New Price Targets
Several brokerages recently weighed in on GLAPF. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Glanbia in a research note on Friday, June 26th. Oddo Bhf downgraded shares of Glanbia to a “neutral” rating in a report on Wednesday. Finally, Barclays restated an “overweight” rating on shares of Glanbia in a research report on Wednesday, June 17th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.
Check Out Our Latest Research Report on GLAPF
Glanbia Price Performance
About Glanbia
Glanbia plc is a global nutrition group headquartered in Kilkenny, Ireland, with roots tracing back to the merger of Avonmore and Waterford agricultural cooperatives in 1997. The company is organized around two main divisions: Performance Nutrition, which focuses on sports and lifestyle-forward consumer products, and Glanbia Nutritionals, which supplies nutritional ingredients and custom formulation services to food, beverage and pharmaceutical customers.
Under its Performance Nutrition arm, Glanbia markets well-known brands of protein powders, bars and ready-to-drink beverages designed for athletes, fitness enthusiasts and wellness-focused consumers.
Recommended Stories
- Five stocks we like better than Glanbia
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
